Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'.
Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G. Iudici M, et al. Among authors: moroncini g. Autoimmun Rev. 2016 Feb;15(2):202. doi: 10.1016/j.autrev.2015.06.007. Epub 2015 Jun 26. Autoimmun Rev. 2016. PMID: 26123179 No abstract available.
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†, Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG), Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Among authors: moroncini g. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV. Gabrielli A, et al. Among authors: moroncini g. Autoimmun Rev. 2007 Dec;7(2):121-6. doi: 10.1016/j.autrev.2007.02.020. Epub 2007 Mar 28. Autoimmun Rev. 2007. PMID: 18035321 Review.
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A; Imatinib in Scleroderma Italian Study Group. Fraticelli P, et al. Among authors: moroncini g. Arthritis Res Ther. 2014 Jul 8;16(4):R144. doi: 10.1186/ar4606. Arthritis Res Ther. 2014. PMID: 25007944 Free PMC article. Clinical Trial.
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?
Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G. Iudici M, et al. Among authors: moroncini g. Autoimmun Rev. 2015 Jul;14(7):575-8. doi: 10.1016/j.autrev.2015.02.002. Epub 2015 Feb 21. Autoimmun Rev. 2015. PMID: 25709096 Review.
Agonistic antibodies in systemic sclerosis.
Moroncini G, Svegliati Baroni S, Gabrielli A. Moroncini G, et al. Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Immunol Lett. 2018. PMID: 29032187 Review.
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.
Moroncini G, Benfaremo D, Mandolesi A, Gabrielli A. Moroncini G, et al. BMJ Case Rep. 2018 May 18;2018:bcr2018224829. doi: 10.1136/bcr-2018-224829. BMJ Case Rep. 2018. PMID: 29776943 Free PMC article.
Putative functional pathogenic autoantibodies in systemic sclerosis.
Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Benfaremo D, et al. Among authors: moroncini g. Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1. Eur J Rheumatol. 2020. PMID: 33164733 Free PMC article. Review.
Role of viral infections in the etiopathogenesis of systemic sclerosis.
Moroncini G, Mori S, Tonnini C, Gabrielli A. Moroncini G, et al. Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):3-7. Epub 2013 Jul 22. Clin Exp Rheumatol. 2013. PMID: 23910606 Review.
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.
Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG. Giacomelli R, et al. Among authors: moroncini g. Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Autoimmun Rev. 2019. PMID: 30408582 Review.
56 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback